Navigation Links
Overcoming Taboos, Myths, and Dogmas in Bioethics
Date:12/15/2008

Few areas of public policy have been fraught with as much controversy as bioethics. Although some people dispute whether it is even a discipline, bioethics tackles some of the most complex and sensitive issues confronting modern society. From discussions on abortion to assisted dying, bioethicists are there.

Each novel development in biomedical technology seems to spark rancorous disputes. FUTURE BIOETHICS: OVERCOMING TABOOS, MYTHS, AND DOGMAS (Prometheus Books, $29.98) is an ambitious book that seeks to reframe the debates surrounding current controversies in bioethics. Not only does it explore laws and policies behind bioethics technologies, it also takes a deep look into the personal decisions and ideas of ordinary people.

"Lindsay's discussion of contemporary bioethical issues is distinguished by features that are sorely needed in serious books for the popular audience: clarity without condescension, and depth without obscurantism," says Barbara Forrest, coauthor with Paul R. Gross of Creationism's Trojan Horse: The Wedge of Intelligent Design, "His arguments are informed by common sense, compassion, and respect for ordinary people who must make the life-altering decisions that have become routine not only in modern medical care but in virtually all aspects of life in the modern world."

Those averse to new technologies often express the concern that the new technology is "unnatural" or requires us to "play God." Slogans such as "Frankenfoods" and "sanctity of life" substitute for reasoned argument. For some reason, these phrases became so frequently used that they replaced most facts about the subject.

Bioethicist Ronald A. Lindsay seeks to expose and debunk these myths. As Nature points out, "He does so in a book that is readable rather than obscure, and accessible to the interested lay person as well as to scholars in the field. Reckoning that progress is unlikely unless we can identify some common moral ground, he postulates that argument based on agreed norms can break the deadlock created by over-hyped language and untested dogma. What is needed, he argues, is 'a well-reasoned, pragmatic approach to controversies in bioethics that avoids reliance on taboos, myths and dogma, whether these result from religious or ideological beliefs'. These are fighting words, and Lindsay throws a number of powerful punches."

After describing in detail the proper way to approach and resolve a dispute in bioethics, Lindsay proceeds to analyze several different cutting-edge issues. "By carefully examining and dissecting claims made by many policy makers and ethicists on topics such as assistance in dying, genetic engineering, and embryonic stem cell research, Lindsay shows that all too often these claims are based on instinctive reactions, beliefs that lack factual support, and religious or ideological dogma," notes Nature Through his insightful analysis, Lindsay demonstrates how to achieve pragmatic, progressive solutions to these controversies.

An antidote for misguided thinking, FUTURE BIOETHICS illuminates the way forward to bioethics policies appropriate for the twenty-first century.


'/>"/>

Contact: Lynn Pasquale
publicitydepartment@prometheusbooks.com
800-853-7545
Prometheus Books
Source:Eurekalert  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Overcoming Taboos, Myths, and Dogmas in Bioethics
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the ... for triple negative breast cancer (TNBC), announced today their completion ... program. The YEi Start in France ... grow their business in France and ... to complete an intensive one week immersion in ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
(Date:2/16/2017)... , ... February 16, 2017 ... ... Molecular Research Inc. has further extended its industry leading Biochemistry Services specifically ... offers state-of-the-art cGMP techniques and methods for the biochemical and biosimilar ...
Breaking Biology Technology: